✦ LIBER ✦

Pharmacokinetics of Empagliflozin, a Sodium Glucose Cotransporter-2 (SGLT-2) Inhibitor, Coadministered with Sitagliptin in Healthy Volunteers

✍ Scribed by Tobias Brand, Sreeraj Macha, Michaela Mattheus, Sabine Pinnetti, Hans J. Woerle

Book ID: 118825495
Publisher: Springer Healthcare Communications
Year: 2012
Tongue: English
Weight: 1015 KB
Volume: 29
Category: Article
ISSN: 0741-238X
DOI: 10.1007/s12325-012-0055-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Empagliflozin, a novel selective sodium

Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors

✍ R. Grempler; L. Thomas; M. Eckhardt; F. Himmelsbach; A. Sauer; D. E. Sharp; R. A 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 575 KB

Pharmacokinetics, pharmacodynamics and s

Pharmacokinetics, pharmacodynamics and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in subjects with renal impairment

✍ Macha, S.; Mattheus, M.; Halabi, A.; Pinnetti, S.; Woerle, H. J.; Broedl, U. C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 598 KB

Effect of Gemfibrozil, Rifampicin, or Pr

Effect of Gemfibrozil, Rifampicin, or Probenecid on the Pharmacokinetics of the SGLT2 Inhibitor Empagliflozin in Healthy Volunteers

✍ Macha, Sreeraj; Koenen, Rüdiger; Sennewald, Regina; Schöne, Katja; Hummel, Noemi 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 331 KB

Efficacy and safety of empagliflozin, a

Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemia

✍ Rosenstock, J.; Seman, L. J.; Jelaska, A.; Hantel, S.; Pinnetti, S.; Hach, T.; W 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 659 KB

Lack of Clinically Relevant Drug–Drug In

Lack of Clinically Relevant Drug–Drug Interaction Between Empagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, and Verapamil, Ramipril, or Digoxin in Healthy Volunteers

✍ Macha, Sreeraj; Sennewald, Regina; Rose, Peter; Schoene, Katja; Pinnetti, Sabine 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 520 KB

Sergliflozin, a Novel Selective Inhibito

Sergliflozin, a Novel Selective Inhibitor of Low-Affinity Sodium Glucose Cotransporter (SGLT2), Validates the Critical Role of SGLT2 in Renal Glucose Reabsorption and Modulates Plasma Glucose Level

✍ Katsuno, K.; Fujimori, Y.; Takemura, Y.; Hiratochi, M.; Itoh, F.; Komatsu, Y.; F 📂 Article 📅 2006 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 413 KB